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Brief Definitive Report
The Wiskott-Aldrich  syndrome  (WAS  OMIM 
301000) is an X-linked disorder characterized   
by thrombocytopenia, eczema, and immuno-
deficiency (Thrasher and Burns, 2010). T lym-
phocytes from WAS patients fail to proliferate   
and secrete IL-2 in response to cross-linking of 
the TCR–CD3 complex. Moreover, they exhibit 
actin cytoskeletal defects illustrated by defective 
F-actin polymerization after TCR–CD3 cross-
linking, reduced ability to spread upon contact 
with anti-CD3–coated surfaces, impaired chemo-
taxis in vitro, and poor homing in vivo to lym-
phoid organs (Thrasher and Burns, 2010). NK cell 
function  and  immune  synapse  formation  with 
target cells is also impaired in WAS (Orange et al., 
2002; Gismondi et al., 2004; Stabile et al., 2010).
In T lymphocytes, WASP is almost totally 
complexed with the WASP-interacting pro-
tein (WIP; de la Fuente et al., 2007). A major 
function of WIP is to stabilize WASP and pre-
vent its degradation. WASP protein levels, but 
not mRNA levels, are severely reduced in T cells 
from WIP-deficient mice. Introduction of full-
length  WIP,  but  not  of  WIP  that  lacks  the 
WASP binding domain, restores WASP levels 
in these cells (de la Fuente et al., 2007). We de-
scribe for the first time a patient who presented 
in early infancy with a phenotype of WAS who 
was found to have a homozygous mutation in 
the WIPF1 gene, which encodes WIP.
RESULTS AND DISCUSSION
Clinical characteristics
The index patient was the second female child 
of consanguineous Moroccan parents. She was 
referred at 11 d of age with poor weight gain, 
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A female offspring of consanguineous parents, showed features of Wiskott-Aldrich  
syndrome (WAS), including recurrent infections, eczema, thrombocytopenia, defective T cell 
proliferation and chemotaxis, and impaired natural killer cell function. Cells from this 
patient had undetectable WAS protein (WASP), but normal WAS sequence and messenger 
RNA levels. WASP interacting protein (WIP), which stabilizes WASP, was also undetectable. 
A homozygous c.1301C>G stop codon mutation was found in the WIPF1 gene, which 
encodes WIP. Introduction of WIP into the patient’s T cells restored WASP expression. 
These findings indicate that WIP deficiency should be suspected in patients with features of 
WAS in whom WAS sequence and mRNA levels are normal.
© 2012 Lanzi et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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rotavirus enteritis at 2 mo of age, and acute hepatitis of un-
known etiology at 3 mo of age. No clinical manifestations of   
autoimmunity or bleeding tendency were noted. Because of 
persistent deterioration, failure to gain weight, and poor T cell 
function, at the age of 4.5 mo she underwent unrelated cord 
blood transplantation. 16 mo after the procedure, she is alive and 
well with >98% of T cells, >98% of B cells, 94% of NK cells, 
50% of monocytes, and 41% of granulocytes of donor origin.   
The oral ulcerations resolved after bone marrow transplant, sug-
gesting that they were secondary to deficient immune function.
Immunological analysis
Analysis of peripheral blood revealed low percentages and 
numbers of CD3+ cells (809 cells/µl), with CD8+ cells more 
affected than CD4+ cells (Fig. 1 A and Table S1). 90% of 
an eczematous rash, papulovesicular lesions on the scalp, and 
ulcerative lesions on the hard palate and tongue. A previous 
female sibling suffered from ulcerative and vesicular skin 
lesions and died of sepsis at 4 mo of age.
Laboratory findings included thrombocytopenia (59 × 
103/µl platelets) with normal platelet volume and elevated 
levels of C reactive protein (10.3 mg/dl; Table S1). Blood 
and urine cultures were negative. Stool cultures revealed no 
pathogenic organisms. S. epidermidis and K. pneumoniae grew 
from the skin vesicular lesions. The patient developed respi-
ratory distress and required oxygen supplementation. A tra-
cheal aspirate was positive for respiratory syncytial virus by   
PCR. She was placed on wide-spectrum antibiotic therapy,   
fungal and viral prophylaxis, immunoglobulin replacement, and 
platelet and red cell transfusions as needed. She developed   
Figure 1.  Functional characterization of WIP deficiency. (A) Evaluation of the proportion of T, B, and NK cells on gated lymphocytes in whole blood (top 
and middle row), and of CD4- and CD8-expressing cells on the CD3+ gated cells (bottom row) of a control (Ctrl), the patient (Pt), and a WAS-null patient. Data are 
representative of three independent analyses. (B) T cell proliferation to PHA and anti-hCD3 with or without rIL-2, as assessed by CFSE dilution. PBMCs were used 
and FACS analysis was performed on CD3+ gated cells. The solid gray histogram represents exemplificative profile of unstimulated cells. An overlapping profile 
was obtained from unstimulated cells of control and WAS patients (not depicted). The red, gray, and blue profiles represent CFSE content in stimulated cells from 
patient, control, and a WAS-null patient, respectively. Data are representative of two independent experiments. (C) PBMCs were stimulated with IL-2, and gated 
CD3+ cells were analyzed by FACS for intracellular pSTAT5 using anti-pY694STAT5. The solid line represents the signal in unstimulated patient’s cells, which was 
comparable to that of unstimulated control and WAS-null patient cells (not depicted). The pSTAT5 signal in the rIL-2 stimulated cells from patient, control, and 
WAS patient are indicated in red, gray, and blue, respectively. Data are representative of three independent experiments. (D) Migration of PHA blasts from a 
healthy control, the patient and from a WAS-null patient toward the chemokine IP-10. The gray, red, and blue histograms represent migration of cells from con-
trol, patient, and WAS-null patient, respectively. Data are representative of two independent experiments. (E) Expression of the IP-10 receptor CXCR3 on PHA 
blasts from patient, control, and WAS-null patient. Isotype control staining of patient PHA blasts is shown by the filled histogram and was comparable to that of 
control T cells and WAS patient (not depicted). The CXCR3 signals in cells from patient, control, and WAS patient are indicated in red, gray, and blue, respectively. 
Data are representative of two independent experiments. (F) Expression of CD56, NKp30, NKGD2, and NKp46 on NK cells from patient (red) and control (gray). The 
filled histogram represents isotype control staining of patient NK cells, and was comparable to that of control NK cells (not depicted). Data are representative of 
two analyses. (G) Cytolytic activity by patient and control NK cell lines against the LCL 721.221 target cells, measured as the percentage of net 51Cr release at  
effector (E) to target (T) ratios of 3:1 and 6:1. Data are representative of two independent experiments on the same expanded NK cells.JEM Vol. 209, No. 1  31
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Expression of the IP-10 receptor CXCR3 was lower in the 
patient’s T cells (Fig. 1 E), and may have contributed to their 
failure to migrate toward IP-10. Analysis of cytolytic activity 
of freshly isolated NK cells from the patient was precluded 
by the amount of blood that could be drawn. To circumvent 
this limitation, NK cells were expanded by stimulating T cell–
depleted PBMCs from patient and a control with PHA and 
rIL-2 in the presence of feeder cells (Castriconi et al., 2007). 
The resulting cell lines contained >90% CD56+ NK cells, 
which expressed comparable levels of CD56 on their surface. 
However, expression of NKp30, NKp46, and NKG2D, all of 
which are implicated in NK cytotoxicity, were reduced on the 
patient’s cells (Fig. 1 F). Analysis of cytolytic activity against 
LCL 721.221 target cells demonstrated a drastic reduction in 
the functional activity of the patient’s NK cell line compared 
with that from control (Fig. 1 G). Previous studies have shown 
impaired cytotoxicity of freshly isolated NK cells from WAS 
patients (Gismondi et al., 2004). We have been unable to de-
rive NK cell lines from the WAS patient for direct comparison 
with the NK cell line from our patient.
WIPF1 is mutated in the patient
Although the WAS gene is located on the X-chromosome, 
several cases of WAS in females caused by extreme lyoni-
zation or biallelic WAS mutations have been described   
CD3+ cells were TCR+, and 7% were TCR+. B cell 
number was low (319 cells/µL), whereas the percentage and 
number of CD16+CD56+ NK cells were increased (2,485 
cells/µl; Fig. 1 A and Table S1), as reported in patients with 
WAS (Gismondi et al., 2004). Serum immunoglobulins were 
normal, except for elevated IgE (32 IU/ml).
Because of the clinical similarities between our patient and 
WAS patients we studied in parallel the function of her T cells 
and those from a WAS patient who expressed no detectable 
WASP protein. Analysis of T cell proliferation by CFSE dilu-
tion revealed normal proliferation to PHA, but completely de-
fective proliferation to immobilized anti-CD3 in the patient 
(Fig. 1 B). In contrast, the proliferation of T cells from the 
WAS patient to anti-CD3 was only partially decreased. Ad-
dition of IL-2 failed to correct the inability of the patient’s 
T cells to proliferate to anti-CD3 (Fig. 1 B), and induced 
only modest STAT5 phosphorylation compared with control 
T cells (Fig. 1 C). In contrast, IL-2 completely corrected the 
proliferation of WASP-deficient T cells to anti-CD3 (Fig. 1 B) 
and caused normal STAT5 phosphorylation in these cells 
(Fig. 1 C). Migration toward the C-X-C motif chemokine 
immune protein-10 (IP-10) was abolished in PHA blasts from 
the patient at all three concentrations tested (Fig. 1 D). WASP-
deficient PHA blasts responded to the highest concentra-
tion of IP-10 tested, but not to the lower two concentrations. 
Figure 2.  WIP is mutated in the patient. (A and C) Western blot analysis of WASP (A) and WIP (C) in lysates of PHA T cell blasts. Numbers at the 
bottom indicate densitometric quantification corrected for the actin signal. Data are representative of two experiments. (B and D) qPCR analysis of mRNA 
expression of WAS (B) and WIPF1 (D) in PHA T blasts, relative to the housekeeping gene GAPDH, normalized to 1 for the mean of 25 controls. The gray 
area indicates the range for the 25 controls. Data are representative of three experiments conducted on triplicates. (E) Genomic organization of WIPF1 
(top) and protein structure (bottom) of WIP showing the localization of the mutation and the resulting amino acidic change (in red) from Serine to a pre-
mature termination codon (S434X). The genomic organization shows coding exons, indicated with Roman numbers, and 5 and 3 untranslated regions 
(UTR). Protein structure includes known WIP-interacting protein domains and WASP homology 2 (WH2). (F) Electropherogram depicting the homozygous 
c.1301C>G mutation in exon 6 in the patient and the presence of the same mutation in the heterozygous state in the mother.32 Human WIP deficiency | Lanzi et al.
had a homozygous point mutation c.1301C>G in exon 6 of 
the WIPF1 gene located on chromosome 2 (Fig. 2, E and F). 
This mutation results in a change from serine to premature 
termination in codon 434 (S434X), situated immediately up-
stream of the region encoding the WASP-binding domain of 
WIP (451–485 aa; Ramesh et al., 1997). Both parents were 
heterozygous for the c.1301C>G substitution, confirming 
the autosomal recessive inheritance of the mutation.
Expression of WIP in the patient’s cells corrects the defect 
in WASP expression
We examined whether expression of human WIP (hWIP) in 
the patient’s cells corrects their defective WASP expression. 
PHA T blasts from the patient and a control were transfected 
with vectors expressing EGFP-hWIP fusion protein or EGFP 
alone, and their content of WIP and WASP was determined 
by FACS analysis of intracellular staining. As expected, intro-
duction of EGFP-hWIP, but not EGFP, in the patient’s T cells 
resulted in WIP expression, as indicated by the detection 
of WIP+ cells in the EGFP+ gate (Fig. 3 A). More impor-
tantly, introduction of EGFP-hWIP, but not EGFP, in the 
patient’s  T  cells  resulted  in  increased  WASP  expression  by 
EGFP+ cells (Fig. 3 B). WASP expression in the EGFP-
hWIP–transfected cells from the patient correlated with WIP 
expression  (Fig.  3  C).  These  findings  indicate  that  the   
absence of WIP in the patient’s T cells resulted in WASP   
instability and degradation. Because 
the patient was transplanted at 4.5 mo 
of  age  and  because  of  the  limited 
amounts  of  blood  we  could  obtain 
pretransplant, we were not able to   
examine whether transduction of WIP 
in  the  patients  T  cells  would  restore 
their function or examine the corti-
cal  actin  meshwork  in  the  patient’s   
T cells, which is severely attenuated   
in WIP/ but not WASP/ mice 
(Antón et al., 2002).
Several of the clinical characteris-
tics  and  laboratory  findings  in  the   
patient resemble those found in WAS. 
They  include  recurrent  infections,   
eczematous skin rash, thrombocyto-
penia, T cell lymphopenia affecting 
(Lutskiy et al., 2002; Proust et al., 2005). Western blot   
analysis revealed no detectable WASP in lysates of the pa-
tient’s PHA T blasts (Fig. 2 A). WASP expression in the   
PHA T blasts from both parents was reduced to 50% of nor-
mal as assessed by Western blot compared with the mean 
of four controls (Fig. 2 A and not depicted). Similar results 
were obtained by flow cytometric analysis of PBMCs from 
the patient and her parents (unpublished data). The levels 
of  WAS mRNA in PHA T blasts from the patient and   
her parents were within the normal range of 25 controls   
(Fig. 2 B). Sequencing of the WAS gene in the patient re-
vealed no mutations.
The absence of WASP expression in the patient’s cells, 
despite normal WAS sequence and mRNA expression level, 
suggested that WASP was being degraded. Because WIP   
stabilizes WASP, we examined its expression. Western blot 
analysis of PHA T blasts from the patient revealed no detect-
able WIP (Fig. 2 C). WIP expression in the PHA T blasts 
from both parents was reduced to 50% of normal (n = 4). 
These results were confirmed by flow cytometric analysis of 
PBMCs from the patient and her parents (unpublished data).
Quantitative  PCR  analysis  revealed  that  the  WIPF1 
mRNA level in the patient’s PHA T blasts was at the lowest 
limit of the normal range of 25 controls (Fig. 2 D). WIPF1 
mRNA levels in the parents were in the lower range of nor-
mal. Sequencing of genomic DNA revealed that the patient 
Figure 3.  Introduction of WIP restores 
WASP levels in the patient T cells.  
(A and B) Two-color FACS analysis of expres-
sion of WIP (A) and WASP (B) versus EGFP in 
PHA T cell blasts transfected with vectors 
encoding EGFP-hWIP for patient and control 
and with EGFP alone for the patient. Histo-
grams depicting WIP and WASP expression in 
gated EGFP+ cells are shown in the right pan-
els. (C) Two-color FACS analysis of WASP ver-
sus WIP expression in gated EGFP+ cells. Data 
are representative of two different analyses.JEM Vol. 209, No. 1  33
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(Beckman Coulter). CD3 contamination was <1%. Purified NK cells were 
cultured on irradiated feeder cells in the presence of 100 U/ml of rIL-2 and 
5 µg/ml of PHA (Invitrogen) to obtain activated polyclonal NK cell popu-
lations. Activated polyclonal NK cells were maintained in complete RPMI 
medium containing 1,200 U/ml of rIL-2.
Molecular genetic analyses. Genomic DNA was isolated using the auto-
matic DNA extractor Maxwell 16 (Promega). Sequencing of genomic DNA 
corresponding to the coding regions of WAS (ENSG00000015285) and 
WIPF1 (ENSG00000115935) genes was performed by direct sequencing   
after PCR amplification of exons with flanking intronic regions. Primers   
and conditions are reported in Table S2.
Total RNA was isolated from PBMCs using the RNeasy Mini kit 
(QIAGEN) and transcribed into complementary DNA (cDNA). Quanti-
tative PCR experiments were performed by reverse transcription of 200 ng   
of DNase-treated total RNA to synthesize the first strand of cDNA by 
the GeneAmp RNA PCR kit (Applied Biosystems). Analysis of WASP, 
WIPF1, and GAPDH gene expression was assessed by RealTime PCR 
using Assays-on-Demand products and TaqMan Master Mix from Ap-
plied Biosystems. The level of expression was normalized using GAPDH 
as a reference.
Immunoblotting. Cell lysates from PHA T blasts were prepared and 10 µg 
protein were loaded on a 10% SDS-PAGE and transferred onto a polyvinyli-
dene fluoride membrane (GE Healthcare). Specific proteins were detected   
using mouse IgG1 anti-WIP mAb (3D10; Koduru et al., 2007), mouse IgG2a 
anti-WASP mAb 5A5 (BD), and mouse anti-actin mAb (US Biological).
Flow cytometry. Flow cytometry for surface and intracellular proteins was 
performed on 100 µl of whole blood or isolated cells (1.5 × 106) resuspended 
in 100 µl of the appropriate medium. To assess WASP and WIP expression, 
cells were treated with the Fix and Perm kit (Invitrogen) for FACS analysis. 
Cells were stained with mouse IgG1 anti WIP (3D10; Koduru et al., 2007) 
and mouse IgG2a anti-WASP (5A5; BD), followed by anti IgG1PE and bio-
tinylated anti–IgG2a-streptavidinPECy5, respectively. Acquisition was per-
formed using a FACSCalibur (BD), and data were analyzed with FlowJo 
Software v7.5 (Tree Star).
Standard flow cytometric methods were also used for CFSE assay. CFSE 
labeling (100 nM) was performed in PBS for 6 min at 37°C. Cells were then 
washed twice in RPMI 10% FCS. Cells were cultured for 96 h in the ab-
sence of stimulation or stimulated with anti-CD3 (clone OKT3, 100 ng/ml) 
and anti–human CD28 (1 µg/ml) or PHA (5 µg/ml) and then analyzed for 
CFSE dilution.
For the characterization of NK cells, the following mAbs, which were 
produced in our laboratories, were used in this study: BAB281 (IgG1anti-
NKp46), AZ20 (IgG1, anti-NKp30), c218 (IgG1, anti-CD56), BAT221 
(IgG1, anti-NKG2D), and 289 (IgG2a, anti-CD3). For cytofluorimetric 
analysis, cells were stained with mAb PE-conjugated isotype-specific goat 
anti–mouse secondary antibody (SouthernBiotech). Cell acquisition was 
performed on a FACScan flow cytometer (BD), and data were analyzed   
using the CellQuest software (BD).
Lymphocyte functional analysis. Analysis of STAT5 phosphorylation in 
T cells in response to IL-2 was assessed by flow cytometry: 100 µl of whole 
blood was incubated with or without 100 ng/ml rIL-2 (Proleukin-Chiron) 
for 10 min at 37°C. Activation was stopped using Lyse/Fix buffer (BD).   
After washing, the samples were permeabilized by PBIII Buffer (BD) for   
30 min on ice and incubated with anti–phospho-STAT5 (Y694)-PE and CD3-
FITC, or with isotype-matched mAb PE (BD) for 30 min at room tempera-
ture. Samples were then washed and resuspended in 200 µl of BD CellFix 
and analyzed with FACSCalibur instrument (BD). To analyze NK cytolytic 
activity, PBMCs were depleted of T cells and expanded in vitro with rIL-2, 
resulting in highly enriched (>95%) CD56+ NK lymphocytes, which were 
tested for cytolytic activity against the NK-susceptible tumor target cell line 
LCL 721.221 in a 4-h 51Cr-release assay. Target cells were used at 5 × 103 
cells/well with final E/T ratios of 6:1 and 3:1.
CD8+ lymphocytes more severely, impaired T cell prolifer-
ation to immobilized anti-CD3, defective T cell chemotaxis, 
and increased NK cell number but decreased NK cell func-
tion. In addition, the patient displayed immune abnormalities 
that are observed in WIP-deficient mice, but not in WAS 
patients or WASP-deficient mice. They include complete 
failure to proliferate to TCR ligation with anti-CD3, im-
paired response of T cells to IL-2, and complete abrogation 
of T cell chemotaxis (Fig. 1; Haddad et al., 2001; Gallego   
et al., 2006; Le Bras et al., 2009). In contrast to WAS patients, 
platelet volume was normal in the patient, like in WIP-deficient 
mice (Curcio et al., 2007). However, we hesitate to draw a 
firm conclusion on platelet size in human WIP deficiency 
based on a single patient.
Despite undetectable WASP in the patient, no mutations 
were detected in the coding region of the WAS gene and 
WAS mRNA levels were normal, findings strongly indica-
tive of WASP instability. WIP, which is critical for the sta-
bility of WASP, was undetectable in the patient’s cells, and 
a homozygous mutation that introduces a premature stop 
codon in the WIPF1 coding sequence was identified in the 
patient. The same mutation was found in the heterozygous 
state in both parents, indicating that WIP deficiency was 
inherited as an autosomal recessive trait. This is consistent 
with an older sibling having died from a similar condition. 
The fact that both parents showed reduced levels of WIP, 
to approximately half of normal, suggests a gene dose effect. 
The correspondingly reduced WASP level in the parents 
suggests that WIP tightly regulates WASP levels. We have 
observed a similar reduction of WASP levels in mice het-
erozygous for a WIP-null allele (unpublished data). Impor-
tantly, we demonstrated that reconstitution of the patient’s 
T cells with WIP restores WASP levels, indicating that loss 
of WIP expression was the cause of WASP instability in the 
patient’s cells.
Collectively, the data indicate that WIP deficiency is re-
sponsible for the immune dysfunction in the patient. Based 
on our findings, WAS cannot be diagnosed solely on the basis 
of lack of WASP expression, but requires sequence analysis of 
WAS. WIP deficiency should be suspected in patients with 
features of WAS in whom WAS sequence and mRNA levels 
are normal, and the diagnosis should be confirmed by se-
quencing WIPF1.
MATERIALS AND METHODS
Cell purification and culture. Patient’s samples were obtained upon in-
formed consent by the local Institution Review Board and in respect to the 
Helsinki declaration. Human studies were approved by the Ethical Commit-
tee of Azienda Ospedaliera Spedali Civili, Brescia. Isolation of peripheral 
blood mononuclear cells (PBMCs) and of specific cell populations and estab-
lishment of cell lines were performed as follow: to obtain PHA T blasts, 
PBMCs were stimulated with 5 µg/ml PHA (Sigma-Aldrich) and 600 U/ml 
rIL-2  (Cairon-Novartis)  in  RPMI  medium  containing  10%  FCS,  1%   
l-glutamine, and 1X antibiotics (EuroClone). To generate NK cell lines, 
NK cells were purified by NK cell separation cocktail (Rosette Sep; StemCell 
Technologies). The purity of NK cells was >96% as assessed by flow cyto-
metric analysis of cells stained with a mixture of CD56-PC5 and CD3-FITC 34 Human WIP deficiency | Lanzi et al.
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Chemotaxis assay. In vitro chemotaxis of PHA T blasts toward IP-10   
was examined using a standard Transwell chamber assay: a total of 3 × 105  
PHA T blasts were added to the upper chamber of a plate 6.5 mm in diameter 
with a pore size of 5 µm (Costar). 600 µl of RPMI 1640 with 0.1% FCS   
was added to the bottom chamber with or without IP10 (250, 500, and   
1,000 ng/ml; PeproTech). After 2 h at 37°C, cells that migrated to the lower 
chamber were collected and counted. The experiment was performed in 
duplicates. Expression of the IP-10 receptor CXCR3 was examined by 
FACS using a mouse anti–CXCR3-FITC mAb (R&D Systems).
WIP  reconstitution  experiment.  hWIP  cDNA  was  generated  from 
normal PBMCs by RT-PCR and cloned into the BglII–PstI cloning sites   
of the pAC-EGFP vector. Confirmation of the WT WIP sequence and its 
in-frame insertion in the vector was obtained by direct sequencing. PHA T 
blasts were transfected using the Amaxa nucleofection technology (Lonza) 
according to the manufacturer’s protocol, which is optimized for stimulated 
human T cells. In brief, 2–3 × 106 cell suspension was mixed with 1 µg/106 
cell of both mock and hWIP-containing plasmid DNA, transfected using the 
T-020 program, then cultured for 48 h in the growth medium. Mock- and 
hWIP-transfected cells were treated with the Fix/Perm kit (Invitrogen) for 
FACS analysis. Cells were stained with mouse IgG1 anti WIP (3D10) and 
mouse IgG2a anti WASP (5A5), followed by anti–IgG1-PE and biotinylated 
anti–IgG2a-streptavidin-PECy5,  respectively.  Acquisition  was  performed 
using a FACSCalibur (BD), and analysis was performed by FlowJo software 
(Tree Star). Transfected PHA-T cells were evaluated for WASP and WIP 
expression level gating on EGFP+ cells.
Online supplemental material. Table S1 provides the Laboratory data of 
the patient at 3 wk of age. Table S2 provides the list of the primers used for 
the amplification of the WIPF1 gene. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20110896/DC1.
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